Neutralizing malaria
نویسندگان
چکیده
منابع مشابه
Malaria drug - resistance in Iran
Introduction: Malaria is a public health problem for approximately 2.4 billion people, 40% of the world’s population, particularly in the tropical and subtropical countries. Countries in Asia, and Latin America, the islands of the South, West, and central pacific ocean are all affected. Drug resistance is the greatest challenge in combating against malaria. Drug resistance in malaria is now w...
متن کاملEpidemiology of Malaria in Kashan
ABSTRACT Every year in the city of Kashan various number of cases of malaria has been observed. Determination of the prevalence of the disease and the carriers in this area of the country can play a significant role in employing preventive measure as well as in managing logistic services. Through applying retrospective descriptive methods and based on the statistics reported from the Center o...
متن کاملPre-exposure Neutralizing Antibody
Maximilian Larena, Natalie A Prow, Roy A Hall, Nikolai Petrovsky and 6 Mario Lobigs 7 8 1 Department of Emerging Pathogens and Vaccines, John Curtin School of Medical 9 Research, The Australian National University, Canberra, Australia 10 2 Australian Infectious Diseases Research Centre, School of Chemistry and Molecular 11 Biosciences, The University of Queensland, St Lucia, Australia 12 3 Vaxi...
متن کاملSkin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity
Malaria eradication will require a combination of vector control, chemotherapy and an easily administered vaccine. Sterile immunity can be elicited in humans by immunization with sporozoites, the infective stage injected by bite of the mosquito vector, however, whole parasite vaccines present formidable logistical challenges for production, storage and administration. The "gold standard" for in...
متن کاملPotent in vivo anti-malaria activity of Goniothalamin against rodent malaria parasite infection in mice
Goniothalamin was evaluated for its anti-malaria activity in-vivo, using the 4-Day Suppressive Test (Peters & Robinson, 1975). The test were carried out against two strains of rodent malaria parasites, the sensitive strain P. berghei ANKA (MRA 311) strain and the resistant strain P. yoelii (MRA 312). An Initial screening was carried out using a single dose of 10 mg/kg body weight administered s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Immunology
سال: 2016
ISSN: 1529-2908,1529-2916
DOI: 10.1038/ni.3404